jacareubin

antibacterial and gastroprotective from the heartwood of Calophyllum brasiliense; structure in first source

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Reyes-Chilpa, R: 2 articles (01/2018 - 11/2017)
2.	Castillo-Arellano, J I: 1 article (01/2018)
3.	González-Espinosa, C: 1 article (01/2018)
4.	Guzmán-Gutiérrez, S L: 1 article (01/2018)
5.	Hernández-Ortega, S: 1 article (01/2018)
6.	Ibarra-Sánchez, A: 1 article (01/2018)
7.	Medina-Campos, O N: 1 article (01/2018)
8.	Nieto-Camacho, A: 1 article (01/2018)
9.	Pedraza-Chaverri, J: 1 article (01/2018)
10.	Estrada-Muñiz, E: 1 article (11/2017)

1.	Neoplasms (Cancer) 11/15/2017 - "Jacareubin is a xanthone isolated from the heartwood of Calophyllum brasiliense with antibacterial and gastroprotective properties and the intention for clinical use as an anti-cancer treatment (due to the similar chemical structure to other anti-neoplastic drugs) requires an investigation of whether this compound can generate adverse effects on non-transformed cells. "
2.	Edema (Dropsy) 01/01/2018 - "In vivo, jacareubin inhibited passive anaphylactic reactions and TPA-induced edema in mice. "
3.	Anaphylaxis (Anaphylactic Shock) 01/01/2018 - "In vivo, jacareubin inhibited passive anaphylactic reactions and TPA-induced edema in mice. "
4.	COVID-19 12/01/2022 - "Xanthone Jacareubin possesses potential anti-COVID-19 properties that, together with the previously tested anti-inflammatory activity, safety, and tolerance, make it a valuable drug to be further investigated for the treatment of cytokine production caused by SARS-CoV-2 infection."